News & updates

Stay updated on our progress

As Arcum Vision™ continues through the development and clinical testing phases, we look forward to keeping you informed about our advancements. We invite you to join us on this exciting journey and be among the first to learn about our progress.

Recent Publications & Talks

Wozniak RAF. WWC 2025 Insights: New Applications for Old Drugs in Corneal Infections. VuMedi. 2025

Maretz C, Atlas J, Shah S, Sohn MB, Wozniak RAF. Infectious Keratitis in Western New York: A 10-Year Review of Patient Demographics, Clinical Management and Treatment Failure. Frontiers Ophthalmology. 2024 doi.org/10.3389/fopht.2024.1469966

Lakshminarayanan G, Wozniak RAF, Dunman PM, Sheba E, Joseph J, Garg P. Efficacy of a Novel Antibiotic Drug Combination Towards Multi-Drug Resistant Ocular Pathogens.  Cornea.  2024; doi:10/1097/ico.3528

Chen ER, Wozniak RAF. Reimagidning the Past: a Future for Antimicrobial Drug Discovery in Ophthalmology. Cornea. 2024; doi:10.1097/ico.3391

Shah S, Wozniak RAF.  Staphylococcus Aureus and Pseudomonas Aeruginosa Infectious Keratitis: Key Bacterial Mechanisms that Mediate Pathogenesis and Emerging Therapeutics.  Frontiers Cellular and Infection Microbiology.  2023.  doi:10.3389/fcimb/2023/1250257

Dunster E, Johnson WL, Wozniak RAF.  Antimicrobial Drug-Drug Interactions in the Treatment of Infectious Keratitis.  Cornea.. 2023; doi:10/1097/ico.3304

Mei JA, Johnson WL, Kinn B, Laskey E, Nolin L, Bhamare P, Stalker C, Dunman PM, Wozniak RAF.  Antimicrobial Activity of a Triple Antibiotic Combination Towards Ocular Pseudomonas Aeruginosa Clinical Isolates.  Translational Vision Science & Technology.  2022; doi:10.1016/j.ajoc.2022.101561

Upcoming Talks

October 18, 2024

Ocular Microbiology and Immunology Group, Chicago IL

Dr. Wozniak presenting on the efficacy of PT + rifampin against multi drug resistant pathogens as the 2024 Harry Hirsch Leiter Award Recipient.

February 20, 2025

Cornea Gordon Research Conference, Ventura CA

Dr. Wozniak presenting on ophthalmic antimicrobial drug development as part of the Translation of Ocular Surface Research into Novel Therapies symposium.

March 22, 2025

World Cornea Congress, Washington DC

Dr. Wozniak presenting on emerging antimicrobial therapeutics  as part of the WCC’s Future Directions Symposium.